Lessons from a large nationwide cohort of 350 children with ovarian mature teratoma: A study in favor of ovarian‐sparing surgery
Pediatric Blood & Cancer2021Vol. 69(3), pp. e29421–e29421
Citations Over TimeTop 21% of 2021 papers
Fanny Delehaye, Sabine Sarnacki, Daniel Orbach, Alaa Cheikhelard, Jérémie Rouger, Jean‐Jacques Parienti, Cécile Faure‐Conter, Frédéric Hameury, Frédérique Dijoud, E. Aubry, Agnès Wacrenier, Édouard Habonimana, Camille Duchesne, S. Joseph, Hortense Alliot, Aurélien Scalabre, Yann Chaussy, Guillaume Podevin, Anne Croué, Élodie Haraux, Marie Pierre Guibal, Isabelle Pommepuy, Quentin Ballouhey, F. Lavrand, Matthieu Peycelon, Sabine Irtan, Florent Guérin, Anne Dariel, Claude Borionne, Louise Galmiche, Julien Rod
Abstract
This study is a plea in favor of OSS as the first-choice treatment of OMT when possible. Close follow-up during the first 5 years is mandatory considering the risk of 8.3% of second events, especially in cases with risk factors.
Related Papers
- → Ovarian teratoma-associated anti-NMDAR encephalitis: a systematic review of reported cases(2014)92 cited
- → Ovarian teratoma associated Anti N-methyl-D-aspartate receptor encephalitis: A difficult diagnosis with a favorable p¬¬rognosis.(2018)31 cited
- → ‘Benign’ ovarian teratoma and N-methyl-D-aspartate receptor (NMDAR) encephalitis in a child(2011)9 cited
- → Teratoma pathology and genomics in anti‐NMDA receptor encephalitis(2023)5 cited